Stage IV Ureter Cancer AJCC v7
3 clinical trials · Condition
◉ Watch Stage IV Ureter Cancer AJCC v7
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery (NCT02812420) | M.D. Anderson Cancer Center | 2017-03-07 |
| Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery (NCT02178241) | National Cancer Institute (NCI) | 2014-12-11 |
| Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer (NCT00942331) | National Cancer Institute (NCI) | 2009-07-15 |
Track Stage IV Ureter Cancer AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.